참고문헌
- Alo PL, Visca P, Marci A, et al (1996). Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer, 77, 474-82. https://doi.org/10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K
- Bauer DE, Hatzivassiliou G, Zhao F, et al (2005). ATP citrate lyase is an important component of cell growth and transformation. Oncogene, 24, 6314-22. https://doi.org/10.1038/sj.onc.1208773
- Blanchette M, Kent WJ, Riemer C, et al (2004). Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res, 14, 708-15. https://doi.org/10.1101/gr.1933104
- Cantor JR, and Sabatini DM (2012). Cancer cell metabolism: one hallmark, many faces. Cancer Discov, 2, 881-98. https://doi.org/10.1158/2159-8290.CD-12-0345
- Cerne D, Zitnik IP, Sok M (2010). Increased fatty acid synthase activity in non-small cell lung cancer tissue is a weaker predictor of shorter patient survival than increased lipoprotein lipase activity. Arch Med Res, 41, 405-9. https://doi.org/10.1016/j.arcmed.2010.08.007
- Chajes V, Cambot M, Moreau K, et al (2006). Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res, 66, 5287-94. https://doi.org/10.1158/0008-5472.CAN-05-1489
- De Schrijver E, Brusselmans K, Heyns W, et al (2003). RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res, 63, 3799-804.
- Dinse GE, Lagakos SW (1982). Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics, 38, 921-32. https://doi.org/10.2307/2529872
- Dolley G, Boisclair ME, Lamarche B, et al (2011). Interactions between dietary fat intake and FASN genetic variation influence LDL peak particle diameter. J Nutrigenet Nutrige, 4, 137-45. https://doi.org/10.1159/000327778
- Eggert SL, Huyck KL, Somasundaram P, et al (2012). Genomewide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata. Am J Hum Genet, 91, 621-8. https://doi.org/10.1016/j.ajhg.2012.08.009
- Flynn R (2012). Survival analysis. J Clin Nurs, 21, 2789-97. https://doi.org/10.1111/j.1365-2702.2011.04023.x
- Goldstraw P, Ball D, Jett JR, et al (2011). Non-small-cell lung cancer. Lancet, 378, 1727-40. https://doi.org/10.1016/S0140-6736(10)62101-0
- Hatzivassiliou G, Zhao F, Bauer DE, et al (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell, 8, 311-21. https://doi.org/10.1016/j.ccr.2005.09.008
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA-Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kao YC, Lee SW, Lin LC, et al (2013). Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma. Tumor Biol, 34, 759-68. https://doi.org/10.1007/s13277-012-0605-y
- Kuhajda FP (2000). Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition, 16, 202-8. https://doi.org/10.1016/S0899-9007(99)00266-X
- Laing RE, Hess P, Shen Y, et al (2011). The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr Drug Metab, 12, 460-86. https://doi.org/10.2174/138920011795495268
- Li N, Bu X, Tian X, et al (2012a). Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. Nutr Cancer, 64, 864-70. https://doi.org/10.1080/01635581.2012.701704
- Li N, Bu X, Wu P, et al (2012b). The “HER2-PI3K/Akt-FASN Axis” regulated malignant phenotype of colorectal cancer cells. Lipids, 47, 403-11. https://doi.org/10.1007/s11745-011-3649-7
- Lin R, Tao R, Gao X, et al (2013). Acetylation stabilizes ATPcitrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell, 51, 506-18. https://doi.org/10.1016/j.molcel.2013.07.002
- Liu HB, Peng YP, Dou CW, et al (2012). Comprehensive study on associations between nine SNPs and glioma risk. Asian Pac J Cancer Prev, 13, 4905-8. https://doi.org/10.7314/APJCP.2012.13.10.4905
- Migita T, Narita T, Nomura K, et al (2008). ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res, 68, 8547-54. https://doi.org/10.1158/0008-5472.CAN-08-1235
- Migita T, Ruiz S, Fornari A, et al (2009). Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst, 101, 519-32. https://doi.org/10.1093/jnci/djp030
- Nguyen PL, Ma J, Chavarro JE, et al (2010). Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol, 28, 3958-64. https://doi.org/10.1200/JCO.2009.27.0793
- Ogino S, Nosho K, Meyerhardt JA, et al (2008). Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol, 26, 5713-20. https://doi.org/10.1200/JCO.2008.18.2675
- Pizer ES, Thupari J, Han WF, et al (2000). Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fattyacid synthase inhibition in human breast cancer cells and xenografts. Cancer Res, 60, 213-8.
- Rahman MT, Nakayama K, Rahman M, et al (2012). Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas. Brit J Cancer, 107, 300-7. https://doi.org/10.1038/bjc.2012.246
- Shastry BS (2009). SNPs: impact on gene function and phenotype. Meth Mol Biol, 578, 3-22. https://doi.org/10.1007/978-1-60327-411-1_1
- Shurbaji MS, Kalbfleisch JH, Thurmond TS (1996). Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol, 27, 917-21. https://doi.org/10.1016/S0046-8177(96)90218-X
- Storey JD, Taylor JE, Siegmund D (2004). Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. J R Stat Soc Series B Stat Methodol, 66, 187-205. https://doi.org/10.1111/j.1467-9868.2004.00439.x
- Swinnen JV, Brusselmans K, Verhoeven G (2006). Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr, 9, 358-65. https://doi.org/10.1097/01.mco.0000232894.28674.30
- Wang Y, Wang Y, Shen L, et al (2012). Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer. Oncol Rep, 27, 1156-62.
- Warburg O (1956). On the origin of cancer cells. Science, 123, 309-14. https://doi.org/10.1126/science.123.3191.309
- Xing J, Myers RE, He X, et al (2011). GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer, 47, 1699-707. https://doi.org/10.1016/j.ejca.2011.02.004
- Yang Y, Liu H, Li Z, et al (2011). Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. Int J Biochem Mol Biol, 2, 89-98.
- Zhou F, He X, Liu H, et al (2012). Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer, 118, 937-46. https://doi.org/10.1002/cncr.26348
피인용 문헌
- Downregulation of fatty acid synthase complex suppresses cell migration by targeting phospho-AKT in bladder cancer vol.13, pp.2, 2015, https://doi.org/10.3892/mmr.2015.4746
- Polymorphisms in Genes of the De Novo Lipogenesis Pathway and Overall Survival of Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1051
- Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma vol.21, pp.11, 2017, https://doi.org/10.1111/jcmm.13213
- ATP-citrate lyase vol.28, pp.2, 2017, https://doi.org/10.1097/MOL.0000000000000390